The Weekly Litigation News Digest is now live. Subscribe now
Use Of Tonicifying Agents To Enhance Recombinant Adeno-Associated Virus Yield - EP3526321
The patent EP3526321 was granted to Dimension Therapeutics on Nov 27, 2024. The application was originally filed on Oct 13, 2017 under application number EP17859455A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP3526321
- Application Number
- EP17859455A
- Filing Date
- Oct 13, 2017
- Status
- Granted And Under Opposition
- Oct 25, 2024
- Publication Date
- Nov 27, 2024
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (19) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents